Skip to main content
. 2018 Feb 14;38(7):1756–1773. doi: 10.1523/JNEUROSCI.2242-17.2018

Figure 6.

Figure 6.

TAT-31-50 administration attenuates the gait alterations induced by CFA injection. A, Schematic diagram of the procedure evaluating gait alterations during STAND (left) or CATWALK (right). B, Consecutive graphs within a duty cycle of the LH and RH 6 h after CFA injection in the LH. C, 3D graphs of the LH print boxed by the red line in B. x-axis: length (0.926 mm per unit), y-axis: width (0.926 mm per unit), z-axis: intensity (A.U.). D–F, STAND intensity (D), CATWALK max intensity (E), and CATWALK mean intensity of the top 15 pixels (F) in TAT-31-50- or TAT-scramble-injected rats at 6 h after CFA injection. Unpaired t test, n = 5 or 6, *p < 0.05, **p < 0.01. G, CATWALK swing duration (% of step-cycle) of LH or RH at 6 h after CFA injection in the LH. Two-way ANOVA, interaction effect: p < 0.05; post test: Sidak's multiple-comparisons test, *p < 0.05. H–J, Correlation analysis between PWL and mechanical threshold (H), intensity data (I), and coordination data (J). Linear regression, n = 11, *p < 0.05, **p < 0.01. For more information, see Figure 6-1.